{"title":"Lilly's Donanemab, will it be the light at the end of the tunnel?","authors":"Jianhong Dong, Ying Wang","doi":"10.59717/j.xinn-med.2023.100006","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":423184,"journal":{"name":"The Innovation Medicine","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Innovation Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59717/j.xinn-med.2023.100006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}